[CH2:1]([NH:8][C:9]1[CH:17]=[C:16]([N:18]2[CH2:23][CH2:22][N:21]([C:24](=[O:31])[C:25]3[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=3)[CH2:20][CH2:19]2)[CH:15]=[CH:14][C:10]=1[C:11]([OH:13])=O)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.CN.C1COCC1.[CH2:39]([N:41](CC)CC)C.C1(P(N=[N+]=[N-])(C2C=CC=CC=2)=O)C=CC=CC=1>C1COCC1>[CH2:1]([NH:8][C:9]1[CH:17]=[C:16]([N:18]2[CH2:19][CH2:20][N:21]([C:24](=[O:31])[C:25]3[CH:26]=[CH:27][CH:28]=[CH:29][CH:30]=3)[CH2:22][CH2:23]2)[CH:15]=[CH:14][C:10]=1[C:11]([NH:41][CH3:39])=[O:13])[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1A solution of 2-(benzylamino)-4-(4-benzoylpiperazin-1-yl)benzoic acid (80 mg, 0.2 mmol), 2 M methylamine THF solution (0.96 ml, 1.9 mmol), triethylamine (0.08 ml, 0.57 mmol) and diphenylphosphoryl azide (0.045 ml, 0.2 mmol) in 15 ml THF was stirred for 16 hours. The run was quenched with 1 ml water and all the solvents were evaporated under vacuum. 2-(benzylamino)-N-methyl-4-(4-benzoylpiperazin-1-yl)benzamide (30 mg, 36%) was obtained by flash column chromatograph (60% ethyl acetate in hexanes). 1H NMR (500 MHz, CDCl3) δ (ppm) 2.97 (d, 3H), 3.14-3.25 (d, br, 4H), 3.65 (s, br, 2H), 3.72 (s, br, 2H), 4.42 (d, 2H), 6.01 (d, J=2.3 Hz, 2H), 6.15 (dd, J=2.3, 8.7 Hz, 1H), 7.26-7.49 (m, 10H), 8.52 (s, 1H). 13C NMR (125 MHz, CDCl3): δ (ppm) 26.9, 47.8, 48.9, 98.3, 103.4, 107.5, 127.5, 127.6, 129.0, 129.1 130.4, 136.0, 139.7, 151.6, 154.3, 170.6, 170.9.
読み込み中…